HerLifeLab Co., Ltd.
Harlife Lab, a startup founded by OIST researchers and gynecologists, launches online menopause medical treatment service “Vivael” ~Seed round funding of 60 million yen from Incubate Fund and Lifetime Ventures~ ……
HerLifeLab Co., Ltd. (Headquarters: Kunigami-gun, Okinawa Prefecture, hereinafter referred to as the Company), whose representative director is Eliseva Olga (hereinafter referred to as Olga), a visiting researcher at Okinawa Institute of Science and Technology Graduate School (OIST), is an online medical treatment service for women suffering from menopausal symptoms. “My Doctor Vivael” will be available from December 11, 2023 (Friday).
In addition, our company conducted a 60 million yen third-party allotment capital increase in the seed round with Incubate Fund, Lifetime Ventures, and others as underwriters. With the funds raised this time, we will build an unprecedented menopause care experience and aim to provide appropriate medical care to women suffering from menopausal symptoms.
[Image 1
◼️About the menopausal online medical treatment service “My Doctor Vivael for Women”
Many women think that “menopause is something to be endured” and spend their days busy with work and childcare without consulting anyone about their health problems. My Doctor for Women “Vivael” is an online gynecological medical treatment service specializing in menopause. Menopause concierges (nurses and midwives specializing in menopause) provide careful counseling on the state of mind and body through dialogue with guests (patients), and handle everything from doctor’s examinations to prescriptions and delivery of prescription drugs. I will do it. The person in charge of the treatment is a veteran gynecologist who has treated thousands of menopausal patients. We care about each individual’s needs and propose the most appropriate treatment method.
Service site URL: https://vivalle-mydoctor.com
[Feature 1.] Individual treatment, care tailored to your physical condition A medical professional specializing in menopause will understand your physical condition and spend time with you to consider the cause. Menopause Concierge carefully understands the changes in the guest’s (patient’s) body and mind, and works with them to come up with a care plan to overcome the fluctuations.
[Feature 2.] Medication options available from Western and Oriental medicine An experienced doctor who is familiar with both Western and Oriental medicine and who has seen many menopausal women will suggest the best treatment from a variety of options, including hormone replacement therapy and Chinese herbal medicine.
[Feature 3.] Easy reservation online, no waiting time online from the first consultation
Online medical treatment is available from the first consultation so that even busy people can visit the clinic in their spare time. [Feature 4.] Medication will be delivered to your home post within a few days Medications are mailed to your home, so even busy people can receive treatment with peace of mind.
【plan】
Symptom understanding plan: 2,900 yen
Medical examination plan: 5,550 yen
Enhancement plan: 12,000 yen
Regular maintenance plan: 8,900 yen / month
◼️Founder profile
[Image 2
Eliseba Olga (Founder, Representative Director and CEO)
Visiting researcher at Okinawa Institute of Science and Technology Graduate University (OIST). Originally from Belarus.
After graduating from the country’s National Medical University, he worked as a doctor at the National Blood Institute before coming to Japan in 1996. After completing his medical degree at Osaka
University, he engaged in cancer immunology research at OIST and RIKEN.
“When I reached menopause, I had a very difficult time receiving support in Japan.I would like to continue researching and researching what is the correct medical care for women, and working to spread this knowledge.”
[Image 3
Kyoko Otsuka (Co-founder, COO)
Completed master’s program at Tokyo Institute of Technology. Invests in startups and promotes collaboration at NTT Docomo Ventures’ Silicon Valley base in the United States. Worked as an alliance manager at RevComm Co., Ltd.
“Because I have been involved in the development of many services, I felt that there were few products that solve the problems unique to women.We aim to be a partner who is close to women’s hearts and creates a happy life together. ”
[Image 4
Naoko Takamiyagi (co-founder, medical advisor, doctor supervising Vivael) Obstetrics and gynecology specialist, women’s healthcare specialist, Menopause counselor
Graduated from Saga Medical University (currently Saga University School of Medicine). Joined the Department of Obstetrics and Gynecology at the same university. Studied abroad at Itokazu Hospital and Center for Reproductive Medicine, Cornell University School of Medicine, USA. Naoko Women’s Clinic opened.
To date, over 7,000 women have experienced menopausal symptoms. Director of Women’s Medical Network. Director of the Japan Women’s Foundation (femship doctor).
◼️Background of service development
Vivael was born after Olga, the company’s representative, had difficulty receiving support in Japan when she reached menopause. One day when I was 44 years old, I suddenly started having severe hot flashes. I thought it was menopause, which I had heard about from my mother and grandmother, so I went to an obstetrician and gynecologist, but they denied it and gave me a prescription that didn’t seem to be effective, and my symptoms did not subside at all.
The doctor at the third hospital finally listened to me for about an hour and sympathized with me by saying, “There are things I don’t understand either, but let’s think about it together and treat each other,” which made me feel much better. I did.
We have developed a medical service specializing in menopause that allows you to immediately consult with a trusted medical professional and access appropriate treatment all at once. By deepening research on women’s health using the knowledge and data gained through providing services in the future, we hope to create a society where women can continue to take on challenges regardless of age or generation. We are aiming for
◼️About seed round funding
In March 2023, we raised seed round funding from two companies: Incubate Fund and Lifetime Ventures. We will accelerate growth by focusing on expanding business development of medical services for menopausal women.
[Investor Comment] Mr. Paul Mclnerney, Incubate Fund
I met President Olga for the first time in 2021, and I was drawn to the vision of solving the menopausal problems of women in Japan and around the world, so we worked together from the business concept stage. In Japan, the proportion of women experiencing menopausal symptoms who receive appropriate treatment is low, and overcoming this situation could have a major impact on the economy. I believe that creating a situation where each person can have the career and life they want will be a great positive for Japanese society as a whole. [Investor Comment] Ryosuke Kimura of Lifetime Ventures
Although the magnitude of unmet medical needs in the area of menopause has been recognized, there have been delays in the development of medical technology and care systems, and
patients/consumers have continued to bear the brunt of the burden for many years. I am really happy to be able to support HerLifeLab and especially Olga, an OIST graduate entrepreneur, as she takes on this big challenge. From Okinawa, one of the world’s five largest longevity areas, the “Blue Zone”, we are delivering fem science projects that reach the world!
[About HerLifeLab]
Company name: HerLifeLab Co., Ltd.
Address: 1919-1 Tancha, Onna Village, Kunigami District, Okinawa Prefecture OIST Innovation Incubator
Representative Director: Eliseva Olga
Established: May 2022
Business content: Femscience business (development of evidence-based products that improve women’s health, medical service planning and system development)
Company website: https://herlifelab.com
Recruitment page:
https://www.notion.so/HerLifeLab-Recruiting-80b5706cfe4744bdbf08ef90f068b311 Contact: pr@herlifelab.com
[Image 5
ENGLISH VERSION
HerLifeLab Inc., led by OIST visiting researcher Eliseva Olga, will launch an online medical service for menopausal women, “My Doctor Vivalle,” starting from December 11, 2023., additionally the company has successfully raised 60 million yen in seed round funding from Incubate Fund and Lifetime Ventures.
About My Doctor Vivalle
Recognizing that menopause is often associated with enduring symptoms without seeking advice, especially for women juggling busy lives with work and childcare, Vivalle aims to provide specialized gynecological care for menopause. Menopause concierges, specialized nurses or midwives, conduct thorough counseling sessions, followed by
comprehensive medical examinations, prescriptions, and delivery of prescribed medications. The physicians are experienced gynecologists, ensuring personalized medical care for each individual.
Key Features:
Individualized Care: Experts spend up to 50 minutes to understand the guest’s health condition and collaboratively consider the underlying causes. Menopause concierges understand carefully changes in the guest’s body and mind, devising a care plan to overcome fluctuations. Choice of Medications from Western and Eastern Medicine: Knowledgeable doctors, experienced in both Western and Eastern medicine, propose optimal treatments from various options, including hormone replacement therapy and Japanese Kampo.
All-Virtual Clinic with Zero Waiting Time: Online consultations are available from the initial visit, allowing even busy individuals to receive medical care during spare moments.
Home Delivery of Medications within a Few Days: Medications are sent to the guest’s home, ensuring convenient access to treatment for those with hectic schedules.
Pricing Plans:
Symptom Assessment Plan: 2,900 yen
Doctor Consultation Plan: 5,550 yen
Comprehensive Care Plan: 12,000 yen
[Yearly] Regular Maintenance Plan: 8,900 yen per month
Founders
Eliseva Olga (Founder, CEO): Visiting researcher at the Okinawa Institute of Science and Technology Graduate University (OIST). Born in Belarus and after graduating from Belarusian State Medical University, worked as a physician at the National Institute of Blood. Came to Japan in 1996, completed her PhD at Osaka University, and engaged in cancer immunology research at OIST and the RIKEN Institute. Kyoko Otsuka (Co-founder, COO): Master’s degree from the Tokyo Institute of Technology Graduate School. Previously involved in startup investment and collaboration promotion at NTT Docomo Ventures’ Silicon Valley branch and served as Alliance Manager at RevComm. Naoko Takamiyagi (Medical Advisor, Supervising Physician at Vivalle): Obstetrician-gynecologist, women’s healthcare specialist, menopause counselor. Graduated from Saga Medical University (currently Saga University School of Medicine) and completed a residency at the university’s obstetrics and gynecology department. Studied at Cornell University Medical College’s Reproductive Medicine Center in the United States.
Background
The inception of Vivalle traces back to Olga’s personal struggle in seeking support during her menopausal period in Japan. Experiencing severe hot flashes at the age of 44, she faced challenges in receiving proper assistance. After multiple attempts, a compassionate doctor finally spent an hour listening and empathizing, leading to a sense of relief. To address the lack of accessible and comprehensive menopausal healthcare, HerLifeLab developed a specialized medical service. The company aims to utilize insights and data gathered during service provision to advance research on women’s health and contribute to creating a society where women can continue to challenge themselves across generations.
Investor Comments:
Paul Mclnerney, Incubate Fund: “From the initial stages of discussing the business concept, I was drawn to Olga’s vision of solving the challenges faced by women during menopause in Japan and around the world. Improving the treatment accessibility for women experiencing menopausal disorders in Japan can have a significant impact on the economy.”
Ryosuke Kimura, Lifetime Ventures: “The menopausal field has long suffered from a lack of medical technology and care infrastructure, leaving patients and consumers bearing the brunt of these issues. We are delighted to support HerLifeLab in resolved this significant challenge, especially with Olga- san, an OIST alum, leading the charge. From Okinawa, one of the world’s five major longevity regions, we look forward to the global reach of FemScience business!” [About HerLifeLab]
Company Name: HerLifeLab Inc.
Location: OIST Innovation Incubator, 1919-1 Yana, Onna Village, Kunigami District, Okinawa Prefecture
CEO: Elisseeva Olga
Established: May 2022
Business: FemScience business (Development of evidence-based products to improve women’s health, planning and system development of medical services)
Company Website: https://herlifelab.com
Recruitment Website:
https://www.notion.so/HerLifeLab-Recruiting-80b5706cfe4744bdbf08ef90f068b311 Contact: pr@herlifelab.com
More details about this release:
https://prtimes.jp/main/html/rd/p/000000001.000133842.html